Internal Medicine, Hematology & Oncology · Henderson, NV
NPI
1427055045
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2460 W Horizon Ridge Pkwy
Henderson, NV, 89052
Phone (702) 822-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
126,433 services
Medicare patients, 2024
492
Average age 74
Drug cost, 2024
$1.7M
1,201 prescriptions
Company payments, 2025
$3,072
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muhammad S Ghani was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 16,830 times for 23 patients. In total Muhammad S Ghani billed 126,433 services in 157 codes, and Medicare paid $1.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-29.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 16,830 | 23 | $0.28 | $4,636 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 12,800 | 17 | $44.72 | $572K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 10,050 | 21 | $0.11 | $1,116 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2,910 | 15 | $5.66 | $16K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,531 | 76 | $0.09 | $224 |
| J0897 Injection, denosumab, 1 mg | Office | 1,740 | 21 | $20.18 | $35K |
| 85025 Blood Count | Office | 1,075 | 287 | $7.61 | $8,177 |
| 36415 Venipuncture Blood Collection | Office | 958 | 293 | $8.65 | $8,287 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 930 | 26 | $0.74 | $690 |
| 99214 Office E&M - Established | Office | 899 | 265 | $98.58 | $89K |
| 80053 Clinical Chemistry | Office | 739 | 220 | $10.35 | $7,649 |
| J9395 Injection, fulvestrant, 25 mg | Office | 540 | 11 | $6.48 | $3,501 |
| 96372 Injection Administration | Office | 421 | 81 | $11.50 | $4,840 |
| 96375 Injection Administration | Office | 359 | 83 | $12.66 | $4,546 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 320 | 16 | $0.25 | $80.49 |
By year: 2022 $2.0M for 131,705 services; 2023 $1.6M for 117,173 services; 2024 $1.9M for 126,433 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,075 | 287 | $7.61 | $8,177 |
| 36415 Venipuncture Blood Collection | 958 | 293 | $8.65 | $8,287 |
| 80053 Clinical Chemistry | 739 | 220 | $10.35 | $7,649 |
| 82728 Clinical Chemistry | 289 | 110 | $13.36 | $3,861 |
| 82784 Immunoassay | 276 | 32 | $9.11 | $2,515 |
| 83540 Clinical Chemistry | 217 | 86 | $6.34 | $1,376 |
| 83550 Clinical Chemistry | 217 | 86 | $8.57 | $1,860 |
| 85610 Clinical Chemistry | 217 | 27 | $4.20 | $911 |
| 83615 Clinical Chemistry | 93 | 46 | $5.92 | $551 |
| 83521 Immunoassay | 89 | 28 | $16.92 | $1,506 |
Medicare prescription drug claims, 2024
In 2024, the drug Muhammad S Ghani prescribed most often to Medicare patients was Oxycodone Hcl, with 92 prescriptions and refills. In total Muhammad S Ghani wrote 1,201 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 92 | 92 | 20 | $3,658 |
| Warfarin Sodium Generic | 80 | 163 | 14 | $771 |
| Letrozole Generic | 52 | 119 | 15 | $719 |
| Eliquis Apixaban | 36 | 88 | 11 | $50K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 32 | 32 | Under 11 | $1,201 |
| Gabapentin Generic | 32 | 37 | Under 11 | $223 |
| Potassium Chloride Generic | 32 | 48 | 11 | $250 |
| Morphine Sulfate Er Morphine Sulfate | 32 | 32 | Under 11 | $916 |
| Amlodipine Besylate Generic | 29 | 67 | Under 11 | $117 |
| Xarelto Rivaroxaban | 26 | 42 | Under 11 | $24K |
| Dexamethasone Generic | 26 | 30 | 12 | $552 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 25 | 25 | Under 11 | $796 |
| Revlimid Lenalidomide | 25 | 25 | Under 11 | $552K |
| Ondansetron Hcl Generic | 22 | 22 | 13 | $238 |
| Furosemide Generic | 22 | 44 | Under 11 | $170 |
Brand drugs: 189 claims; generic drugs: 1,012 claims; opioid claims: 216.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muhammad S Ghani $3,072 ($3,072 in general payments such as food, travel and fees) from 28 companies. The largest payer was Daiichi Sankyo Inc. with $907.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 58 | $907 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $456 |
| Merck Sharp & Dohme LLC MRK | 6 | $177 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $175 |
| Tempus AI, Inc TEM | 8 | $155 |
| Sobi, Inc SOBI.ST | 13 | $152 |
| Gilead Sciences, Inc. GILD | 3 | $101 |
| Karyopharm Therapeutics Inc. KPTI | 3 | $94.98 |
| Genentech USA, Inc. ROG.SW | 4 | $86.88 |
| Exelixis Inc. EXEL | 2 | $78.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.